Triazinone compound and t-type calcium channel inhibitor

Disclosed herein are triazinone compounds of formula I where the substituents are as defined herein or a tautomer or a pharmaceutically acceptable salt of the compound. The compounds have an inhibitory activity on a T-type voltage-dependent calcium channel and are useful particularly for the treatme...

Full description

Saved in:
Bibliographic Details
Main Authors KAWAZU TAKESHI, SHINTANI YUSUKE, INABA YUSUKE, ADACHI MICHIAKI, HIRAI YUICHI, YASUTAKE KOICHI, NAGAI HIROSHI, UENO MEGUMI, EGI JUN, TAKAHASHI DAIKI, SAITO NORIKO
Format Patent
LanguageEnglish
Published 29.04.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed herein are triazinone compounds of formula I where the substituents are as defined herein or a tautomer or a pharmaceutically acceptable salt of the compound. The compounds have an inhibitory activity on a T-type voltage-dependent calcium channel and are useful particularly for the treatment of pain. Also disclosed are therapeutic agents and medicines comprising the compounds.
Bibliography:Application Number: NZ20130626112